2
Participants
Start Date
October 13, 2023
Primary Completion Date
April 29, 2024
Study Completion Date
April 29, 2024
CD-801
The subjects with advanced HCC will be treated by 100 μg CD-801 through the hepatic artery injection at two-week intervals. The dosing interval will be adjusted based on subject tolerability, safety, and efficacy. For example, it may be adjusted to administer the medication once every three weeks or four weeks.
Changzheng Hospital，Naval Medical University, Shanghai
Shanghai Changzheng Hospital
OTHER